Evaluation of apolipoprotein M as a biomarker of coronary artery disease

Clinical Biochemistry

Volumn 42, Issue 4-5, 2009, Pages 365-370

  Su, Weiqiang ^b   Jiao, Guoqing ^a,b   Yang, Chengjian ^b   Ye, Yizhou ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ApoM; Coronary artery disease; HDL; LDL; TC

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN M; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; APOM PROTEIN, HUMAN; LIPOCALIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOT HYBRIDIZATION; EVALUATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED;

APOLIPOPROTEINS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; LIPOCALINS;

EID: 60949113744     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.11.010     Document Type: Article

References (24)

1. Lahoz C., Schaefer E.J., Cupples L.A., Wilson P.W., Levy D., Osgood D., et al. Apolipoprotein E genotyping and cardiovascular disease in the Framingham Heart study. Atherosclerosis 154 (2001) 529-537
2. Frishman W.H. Biologic markers as predictors of cardiovascular disease. Am. J. Med. 104 (1998) 185-275
3. Centers for Disease Control. Effectiveness in disease and injury prevention: public health focus: physical activity and the prevention of coronary heart disease. Morb. Mort. Wkly. Rep. 42 (1993) 669-672
4. Srinivasan S.R., Ehnholm C., Elkasabany A., et al. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood the Bogalusa Heart study. Atherosclerosis 143 (1999) 435-443
5. Xu N., and Dahlback B. A novel human apolipoprotein (ApoM). J. Biol. Chem. 274 (1999) 31286-31290
6. Duan J., Dahlback B., and Villoutreix B.O. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett. 499 (2001) 127-132
7. Ahnström J., Faber K., Axler O., and Dahlbäck B. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. J. Lipid Res. 48 (2007) 1754-1762
8. Richter S., Shih D.Q., Pearson E.R., Wolfrum C., Fajans S.S., Hattersley A.T., et al. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 52 (2003) 2989-2995
9. Axler O., Ahnström J., and Dahlbäck B. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J. Lipid Res. 48 (2007) 1772-1780
10. Jungner I., Marcovina S.M., Walldius G., Holme I., Kolar W., and Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin. Chem. 44 (1998) 1641-1649
11. Kannel W.B., Castelli W.P., Gordon T., and McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med. 74 (1971) 1-12
12. Kannel W.B., Neaton J.D., Wentworth D., Thomas H.E., Stamler J., Hulley S.B., et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am. Heart J. 112 (1986) 825-836
13. Mensah G.A., Brown D.W., Croft J.B., and Greenlund K.J. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). Am. J. Prev. Med. 29 (2005) 68-74
14. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
15. Jiao G.Q., Yuan Z.X., Xue Y.S., Yang C.J., Lu C.B., Lu Z.Q., et al. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese. Clin. Biochem. 40 (2007) 1108-1112
16. Genisi G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 51 (1983) 606
17. Axler O., Ahnström J., and Dahlbäck B. Apolipoprotein M associates to lipoproteins through its retained signal peptide. FEBS Lett. 582 (2008) 826-828
18. Wolfrum C., Poy M.N., and Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11 (2005) 418-422
19. Christoffersen C., Jauhiainen M., Moser M., Porse B., Ehnholm C., Boesl M., et al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J. Biol. Chem. 25 (2008) 1839-1847
20. Christoffersen C., Nielsen L.B., Axler O., Andersson A., Johnsen A.H., and Dahlbäck B. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res. 47 (2006) 1833-1843
21. Faber K., Hvidberg V., Moestrup S.K., Dahlbäck B., and Nielsen L.B. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol. Endocrinol. 20 (2006) 212-218
22. Karlsson H., Leanderson P., Tagesson C., and Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5 (2005) 551-565
23. Karlsson H., Lindqvist H., Tagesson C., and Lindahl M. Characterization of apolipoprotein M isoforms in low-density lipoprotein. J. Proteome Res. 5 (2006) 2685-2690
24. Mancone C., Amicone L., Fimia G.M., Bravo E., Piacentini M., and Tripodi M. Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics 7 (2007) 143-154